BIVI
NASDAQ
$1.43
BioVie Inc - Class A (BIVI)
BioVie Inc., a clinical-stage biotechnology company, is dedicated to the discovery, development, and commercialization of drug therapies in the United States. The company is headquartered in Santa Monica, California.
This company is also listed under the following ticker: BIVIW.
Website: https://bioviepharma.comSector:
Healthcare
Industry:
Biotechnology
Target: $5 (+250.88%)
Market Cap
$13M
P/B Ratio
0.76
FCF 5Y CAGR
+57.43%
Beta (5Y)
1.89
Price Chart
Valuation
Market Cap$13M
P/B0.76
Profitability
EBITDA-$20M
EPS-$4.00
Growth & Risk
EPS 5Y CAGR+13.37%
FCF 5Y CAGR+57.43%
Beta (5Y)1.89
Sharpe Ratio-1.15